Jeil Pharmaceutical

제일약품 · 271980

Health Care Pharmaceuticals · KOSPI

Small-cap

Market cap US$117.1M (₩161.6B)

Overview

Jeil Pharmaceutical makes prescription and over-the-counter medicines used by patients and healthcare providers in South Korea.

Its products are supplied through hospitals, clinics, and pharmacies. The company is listed on KOSPI, South Korea's main stock exchange, and remains profitable despite a recent decline in revenue.

Summary is AI-generated and may contain errors · figures from DART filings

Financials

Source: DART · FY ending Dec · latest FY2025

Revenue · FY2025

US$411M

▼ −19.5% YoY

Operating profit · FY2025

US$15M

Turned profitable

Net income · FY2025

US$23.2M

Turned profitable

Revenue, operating profit and net income by fiscal year (USD; KRW in parentheses).
Metric	FY2023	FY2024	FY2025
Revenue	US$526.4M(₩726.4B)	US$510.5M(₩704.5B)	US$411M(₩567.2B)
Operating profit	US$6.3M(₩8.7B)	−US$13.7M(−₩18.9B)	US$15M(₩20.7B)
Net income	US$3.8M(₩5.2B)	−US$21.8M(−₩30.1B)	US$23.2M(₩32B)

Revenue

FY2023US$526.4M
FY2024US$510.5M
FY2025US$411M

Operating profit

FY2023US$6.3M
FY2024−US$13.7M
FY2025US$15M

Net income

FY2023US$3.8M
FY2024−US$21.8M
FY2025US$23.2M

Key ratios (FY2025)

ROE

12.8%

Debt/Eq

103.4%

Op. margin

3.6%

Net margin

5.6%

Rev. YoY

▼ −19.5%

Price charts coming soon

Interactive price history isn't here yet. Would you use it?